Original Article
Sarcopenia following concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1358-1365
.
(30 August 2025)
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1366-1379
.
(30 August 2025)
Poorer prognosis of early gastric cardia cancer compared to early gastric non-cardia cancer: evidence from SEER database analysis
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1380-1392
.
(30 August 2025)
Tumor necrosis, an independent prognostic factor for predicting gastric gastrointestinal stromal tumors
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1393-1402
.
(30 August 2025)
Global burden of gastric cancer attributed to high-salt diets: spatiotemporal trends and socio-demographic inequalities from 1990 to 2021
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1403-1419
.
(30 August 2025)
Retrospective analysis of Claudin18.2 expression in ethnically diverse patients with gastroesophageal adenocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1420-1433
.
(30 August 2025)
Value of the systemic immune inflammation index in predicting the efficacy of neoadjuvant chemotherapy in patients with gastric cancer: a multicenter retrospective clinical study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1434-1442
.
(30 August 2025)
NKAP overexpression promotes gastric cancer immune escape by inducing IL-10 secretion from mature dendritic cells during anti-PD-L1 therapy
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1443-1460
.
(30 August 2025)
The clinical value of spectral computed tomography reconstruction technology for the anatomy of the superior mesenteric artery in laparoscopic radical right hemicolectomy for colon cancer: a cross-sectional study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1461-1473
.
(30 August 2025)
Diagnostic value of endoscopic ultrasound versus indocyanine green fluorescence imaging for sentinel and lymph node metastasis in patients with colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1474-1482
.
(30 August 2025)
Prognostic nomogram for overall survival in rectal cancer with synchronous lung metastases using Surveillance, Epidemiology, and End Results data and a single-center external validation cohort
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1483-1497
.
(30 August 2025)
Proximal vs. distal colon cancer location: a subset analysis of the Minnesota colon cancer control study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1498-1502
.
(30 August 2025)
Identification of prognostic biomarkers in colorectal cancer through multi-omics profiling of programmed cell death pathways
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1503-1520
.
(30 August 2025)
Colorectal cancer prognosis: insights from the tumor immune microenvironment and gut microbiota
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1521-1533
.
(30 August 2025)
Fear of cancer recurrence and associated factors in Chinese patients with colorectal cancer: a cross-sectional study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1534-1549
.
(30 August 2025)
Andrographolide potentiates anti-tumor immunity in colorectal cancer (CRC) by targeting voltage-dependent anion channel (VDAC) and activating the cGAS-STING axis
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1550-1561
.
(30 August 2025)
Establishment of a prognostic nomogram for intrahepatic cholangiocarcinoma patients receiving chemotherapy: a SEER-based study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1562-1572
.
(30 August 2025)
Tumor-informed circulating tumor DNA assay for surveillance post-liver transplantation in patients with hepatocellular and cholangiocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1573-1585
.
(30 August 2025)
Survival of hepatectomy in colorectal cancer patients with ten or more liver metastases: a retrospective cohort study of multidisciplinary treatment
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1586-1596
.
(30 August 2025)
Real-world second-line treatment pattern for unresectable or advanced hepatic carcinoma in China: a retrospective database study
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1597-1609
.
(30 August 2025)
Efficacy of stereotactic body radiotherapy in hepatocellular carcinoma with adrenal metastases: a retrospective analysis
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1610-1621
.
(30 August 2025)
DDX18 promotes growth and metastasis of hepatocellular carcinoma via activating EMT and MAPK signaling
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1622-1634
.
(30 August 2025)
GBA3 as a regulator of sphingolipid metabolism in the progression of hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1635-1647
.
(30 August 2025)
Clinical significance of transjugular intrahepatic portosystemic shunting for hepatocellular carcinoma complicated with portal hypertension
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1648-1657
.
(30 August 2025)
Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a predictor of progression-free survival
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1658-1666
.
(30 August 2025)
The incidence and risk factors of venous thromboembolism in patients with pancreatic cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1667-1681
.
(30 August 2025)
Local radiotherapy polarized tumor-associated macrophages enhance the efficacy of Claudin18.2-targeted CAR-T therapy in pancreatic cancer
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1682-1698
.
(30 August 2025)
Mechanistic insights into the anti-tumor effects of neochlorogenic acid in hepatocellular carcinoma: in vitro and in vivo studies
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1699-1710
.
(30 August 2025)
A novel lactylation-related signature for predicting esophageal cancer prognosis and immune infiltration
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1711-1735
.
(30 August 2025)
Case Series
The combination of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), interventional hepatoma therapy, targeted therapy, and immunotherapy: a case series of a novel AITI conversion therapy model
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1736-1748
.
(30 August 2025)
Case Report
A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1749-1755
.
(30 August 2025)
Case report of carcinoid syndrome with multi-organ involvement
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1756-1762
.
(30 August 2025)
Editorial Commentary
Rethinking surrogate endpoints in metastatic colorectal cancer: counting chickens only when they hatch
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1763-1767
.
(30 August 2025)
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1768-1772
.
(30 August 2025)
Editorial
New dosing schedules in pre-treated patients with metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1773-1778
.
(30 August 2025)
Progress in precision therapies for advanced cholangiocarcinoma: inhibitors of FGFR1–3
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1779-1781
.
(30 August 2025)
Impact of new onset diabetes on pancreatic cancer outcomes
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1782-1784
.
(30 August 2025)
Efficacy of liquid biopsy in colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1785-1788
.
(30 August 2025)
Erratum
Erratum: Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1789-1790
.
(30 August 2025)
Erratum: Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK
Journal of Gastrointestinal Oncology
2025;
16
(4)
:1791-1795
.
(30 August 2025)
